LATANOPROST Ophthalmic Solution 0.005% "KAKEN"（ラタノプロスト点眼液0.005％「科研」）
Brand name : LATANOPROST Ophthalmic Solution 0.005% "KAKEN"
Active ingredient: Latanoprost
Dosage form: clear and colorless sterile eye solution (2.5mL)
Print on wrapping: ラタノプロスト点眼液0.005%「科研」, 2.5mL
Effects of this medicine
This medicine lowers eye pressure by increasing fluid drainage from the aqueous outflow pathway of the eye.
It is usually used to treat glaucoma and ocular hypertension.
Before using this medicine, be sure to tell your doctor and pharmacist
•If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have: aphakic eye or pseudophakic eye, intraocular inflammation (e.g. iritis, uveitis), possible herpesvirus infection, bronchial asthma or history of bronchial asthma.
•If you are pregnant or breastfeeding.
•If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule (How to take this medicine)
•Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>>
•In general, apply 1 drop at a time, once a day. Strictly follow the instructions.
•Wash hands down and apply carefully not to touch the dropper tip against the eye.
•Wipe off any excess liquid with a clean wet gauze or tissue.
•If you are using other eye drops at the same time, wait more than 5 minutes.
•If you are wearing contact lenses, take off the lenses and then administer. Wait more than 15 minutes to wear your contact lenses again. (It might lead contact lenses to discoloration).
•If you miss a dose, apply one drop once if it is within the day. You should never apply twice a day nor two drops at a time when you noticed the missed dose the next day. (By the frequent dosage, intraocular pressure decreasing action may attenuate.)
•If you accidentally use more than your prescribed dose, consult with your doctor or pharmacist.
•Do not stop using this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
•Applying the eye-drops may cause iris pigmentation, followed by gradual increase of the symptom. The symptom may stop after withdrawal of the eye-drops, but there may be difference in color tone compared to the other eye without eye-drop treatment. If you become aware of it, check with your doctor.
•This medicine may cause transient blurred vision. Avoid driving a car or operating machinery until these symptoms recover.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include conjunctival hyperaemia, ocular irritancy symptom, itching, eye pain, blepharitis (eye lid infection), eyelid pigmentation, blurred vision, abnormal eyelash, visual acuity decrease, lacrimation, headache, throat discomfort and nausea. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
•pupil color change [iris pigmentation]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
•Keep out of the reach of children. Store away from light, heat and moisture.
•Discard the remainder. Do not store them.
Kaken Pharmacetical Co.,LtdExternal
Published: 5/2010
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
http://meds.qlifepro.com/detail/621984501/latanoprost |
